...
首页> 外文期刊>Nuclear Medicine Communications >The value of 99mTc-MDP bone scintigraphy in staging primary lymphoma of bone.
【24h】

The value of 99mTc-MDP bone scintigraphy in staging primary lymphoma of bone.

机译:99mTc-MDP骨显像在分期原发性骨淋巴瘤中的价值。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To assess the value of (99m)Tc-MDP bone scintigraphy in the staging of primary bone lymphoma. MATERIALS AND METHODS: Thirteen staging scintigrams of patients with biopsy proven primary bone lymphoma were reviewed. The number and location of involved sites of disease were documented in each case. RESULTS: Seven out of 13 scintigrams (54%) demonstrated a single site of bone involvement. Six cases (46%) showed multifocal disease, including clinically silent weight-bearing sites. CONCLUSIONS: Bone scintigraphy is a valuable tool in the staging of primary bone lymphoma. It detects multifocal involvement which alters prognosis and possibly treatment. Clinically silent involvement of weight-bearing sites may be detected allowing prophylactic treatment if required.
机译:目的:评估(99m)Tc-MDP骨显像在原发性骨淋巴瘤分期中的价值。材料与方法:回顾了经活检证实为原发性骨淋巴瘤的患者的13个分期闪烁图。在每种情况下都记录了疾病累及部位的数量和位置。结果:13个闪烁图中有7个(54%)显示出一个单一的骨受累部位。 6例(46%)表现出多灶性疾病,包括临床上无声的负重部位。结论:骨闪烁显像是原发性骨淋巴瘤分期的一种有价值的工具。它可以检测多灶性受累,从而改变预后和可能的治疗方法。可以检测到负重部位的临床沉默感染,必要时可以进行预防性治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号